Skip to main content
. 2021 Jan 28;235:54–64. doi: 10.1016/j.ahj.2021.01.018

Figure 1.

Figure 1

Potential Cardioprotective Mechanisms of Icosapent Ethyl. This figure has been reproduced with permission from Darwesh et al. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?Pharmacol Ther. 2020 Oct 5: 107703. PMCID: PMC7534795.